Jessica Lynn has an educational background in writing and marketing. She firmly believes in the power of writing in amplifying voices, and looks forward to doing so for the rare disease community.

    Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. II)
    Katheron Intson

    Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. II)

    Don't forget to check out Part 1 of our interview with Katheron Intson, where we discussed her background, her research experience in GRIN1, and the reasons behind why she developed…

    Continue Reading Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. II)
    Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. 1)
    Katheron Intson

    Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. 1)

    Katheron Intson is a passionate scientist; she likes understanding how and why things work the way that they do. So when Katheron’s friend reached out about a mysterious health problem,…

    Continue Reading Accelerating the Journey to Rare Disease Treatment: An Interview with Katheron Intson of Varient (Pt. 1)
    Researchers Determine Effective Therapeutic Candidates for Crimean-Congo Hemorrhagic Fever
    source: pixabay.com

    Researchers Determine Effective Therapeutic Candidates for Crimean-Congo Hemorrhagic Fever

    Endemic in areas of Africa, southeast Europe, Central Asia, and the Middle East, Crimean-Congo hemorrhagic fever is an often-fatal viral illness which can cause severe issues. Researchers estimate that this…

    Continue Reading Researchers Determine Effective Therapeutic Candidates for Crimean-Congo Hemorrhagic Fever
    TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
    Rheumatoid arthritis. Source: James Heilman, MD / CC BY-SA (https://creativecommons.org/licenses/by-sa/3.0)

    TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA

    In the past, certain research has suggested a relationship between the use of therapies like TNF inhibitors, tocilizumab, and tofacitinib, and a heightened risk of Alzheimer’s disease (AD) or dementia.…

    Continue Reading TNF Inhibitors Do Not Increase Dementia Risk in Patients with RA
    Can Music Therapy Relieve SCD Pain?
    https://pixabay.com/en/guitar-music-man-play-strum-chord-869217/

    Can Music Therapy Relieve SCD Pain?

    Many patients with sickle cell disease (SCD) experience “pain crises,” or periodic episodes of extreme pain. These pain crises occur when sickle-shaped red blood cells block the flow of blood…

    Continue Reading Can Music Therapy Relieve SCD Pain?
    Donidalorsen Reduces HAE Attacks, Study Shows
    Hand swollen during hereditary angioedema attack. Sourced from Wikimedia Commons

    Donidalorsen Reduces HAE Attacks, Study Shows

    In patients with hereditary angioedema (HAE), the C1-inhibitor blood protein does not function properly, allowing bradykinin peptides to build up in the body. These then cause inflammation and fluid leakage;…

    Continue Reading Donidalorsen Reduces HAE Attacks, Study Shows